Search research articles
Contact Us
Filters
Showing results (41-50 of 98) with videos related to
Page
of 10
Sort By:
Frontiers in Immunology
|
August 15, 2024
Overcoming limitations for antibody-based therapies targeting γδ T (Vg9Vd2) cells
Lucía Paniagua-Herranz, Cristina Díaz-Tejeiro, Adrián Sanvicente, et al.
Cancer Treatment Reviews
|
July 23, 2017
Influence of non-measurable disease on progression-free survival in patients with metastatic breast cancer
Hadar Goldvaser, Domen Ribnikar, Rouhi Fazelzad, et al.
BMC Cancer
|
May 1, 2014
Phospho-kinase profile of triple negative breast cancer and androgen receptor signaling
María D Cuenca-López, Juan C Montero, Jorge C Morales, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 6, 2014
Raising concern about the American Society of Clinical Oncology conflict of interest policy amendment
Francisco E Vera-Badillo, Alberto Ocana, Arnoud J Templeton, et al.
Molecular Diagnosis & Therapy
|
February 2, 2022
Prognostic Value of Programmed Death Ligand-1 Expression in Solid Tumors Irrespective of Immunotherapy Exposure: A Systematic Review and Meta-Analysis
Ramy R Saleh, Jordan L Scott, Nicholas Meti, et al.
Scientific Reports
|
May 26, 2021
Efficacy, safety and tolerability of drugs studied in phase 3 randomized controlled trials in solid tumors over the last decade
Domen Ribnikar, Hadar Goldvaser, Zachary W Veitch, et al.
The Lancet. Oncology
|
June 15, 2016
Under-reporting of harm in clinical trials
Bostjan Seruga, Arnoud J Templeton, Francisco Emilio Vera Badillo, et al.
Geroscience
|
June 19, 2025
NRF2 pathway activation predicts poor prognosis in lung cancer: a cautionary note on antioxidant interventions
Zoltan Ungvari, Otília Menyhart, Andrea Lehoczki, et al.
Plos One
|
March 4, 2014
Extended adjuvant tamoxifen for early breast cancer: a meta-analysis
Mustafa Al-Mubarak, Ariadna Tibau, Arnoud J Templeton, et al.
Cancer Treatment Reviews
|
April 25, 2017
Efficacy, safety, tolerability and price of newly approved drugs in solid tumors
Tristan A Barnes, Eitan Amir, Arnoud J Templeton, et al.
Page
of 10
Search research articles
Search
Showing results (41-50 of 98) with videos related to
Sort By:
Page
of 10
Frontiers in Immunology
|
August 15, 2024
Overcoming limitations for antibody-based therapies targeting γδ T (Vg9Vd2) cells
Lucía Paniagua-Herranz, Cristina Díaz-Tejeiro, Adrián Sanvicente, et al.
Cancer Treatment Reviews
|
July 23, 2017
Influence of non-measurable disease on progression-free survival in patients with metastatic breast cancer
Hadar Goldvaser, Domen Ribnikar, Rouhi Fazelzad, et al.
BMC Cancer
|
May 1, 2014
Phospho-kinase profile of triple negative breast cancer and androgen receptor signaling
María D Cuenca-López, Juan C Montero, Jorge C Morales, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 6, 2014
Raising concern about the American Society of Clinical Oncology conflict of interest policy amendment
Francisco E Vera-Badillo, Alberto Ocana, Arnoud J Templeton, et al.
Molecular Diagnosis & Therapy
|
February 2, 2022
Prognostic Value of Programmed Death Ligand-1 Expression in Solid Tumors Irrespective of Immunotherapy Exposure: A Systematic Review and Meta-Analysis
Ramy R Saleh, Jordan L Scott, Nicholas Meti, et al.
Scientific Reports
|
May 26, 2021
Efficacy, safety and tolerability of drugs studied in phase 3 randomized controlled trials in solid tumors over the last decade
Domen Ribnikar, Hadar Goldvaser, Zachary W Veitch, et al.
The Lancet. Oncology
|
June 15, 2016
Under-reporting of harm in clinical trials
Bostjan Seruga, Arnoud J Templeton, Francisco Emilio Vera Badillo, et al.
Geroscience
|
June 19, 2025
NRF2 pathway activation predicts poor prognosis in lung cancer: a cautionary note on antioxidant interventions
Zoltan Ungvari, Otília Menyhart, Andrea Lehoczki, et al.
Plos One
|
March 4, 2014
Extended adjuvant tamoxifen for early breast cancer: a meta-analysis
Mustafa Al-Mubarak, Ariadna Tibau, Arnoud J Templeton, et al.
Cancer Treatment Reviews
|
April 25, 2017
Efficacy, safety, tolerability and price of newly approved drugs in solid tumors
Tristan A Barnes, Eitan Amir, Arnoud J Templeton, et al.
Page
of 10